The much ballyhooed healthcare legislation continues to meander its way through Washington, seemingly getting watered down at every turn. As the House and Senate versions are reconciled, investors are getting a better idea of what kind of changes to expect in the final package. We will try to steer clear of political arguments in this column, and focus more on investment implications. Read more...